Adenovirus expressing IFN-λ1 (IL-29) attenuates allergic airway inflammation and airway hyperreactivity in experimental asthma

International Immunopharmacology

Volumn 21, Issue 1, 2014, Pages 156-162

  Li, Yan ^a   Gao, Qiaoyan ^a   Yuan, Xianli ^a   Zhou, Mi ^a   Peng, Xiao ^a   Liu, Xiaojin ^b   Zheng, Xiaoxuan ^b   Xu, Damo ^a,b,c   Li, Mingcai ^a,b  

^a NINGBO UNIVERSITY   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Airway inflammation; Eosinophils; Hyperresponsiveness; IFN 1 (IL 29); Th2 cells

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 29; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3; ALLERGEN; CYTOKINE; IL29 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADENOVIRUS; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT ALLERGY; SPLEEN LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; ADENOVIRIDAE; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; BLOOD; BRONCHIAL HYPERREACTIVITY; CELL CULTURE; DISEASE COURSE; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METABOLISM; PNEUMONIA;

ADENOVIRIDAE; ADMINISTRATION, INTRANASAL; ALLERGENS; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CELLS, CULTURED; CYTOKINES; DISEASE PROGRESSION; HUMANS; IMMUNOGLOBULIN E; INTERLEUKINS; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; OVALBUMIN; PNEUMONIA; T-LYMPHOCYTES, REGULATORY;

EID: 84901011999     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.04.022     Document Type: Article

References (28)

1. Q. Hamid, and M. Tulic Immunobiology of asthma Annu Rev Physiol 71 2009 489 507
2. J.A. Boyce, D. Broide, K. Matsumoto, and B.S. Bochner Advances in mechanisms of asthma, allergy, and immunology in 2008 J Allergy Clin Immunol 123 2009 569 574
3. P.J. Barnes New therapies for asthma: is there any progress? Trends Pharmacol Sci 31 2010 335 343
4. S.T. Holgate Novel targets of therapy in asthma Curr Opin Pulm Med 15 2009 63 71
5. S.V. Kotenko, G. Gallagher, V.V. Baurin, A. Lewis-Antes, M. Shen, and N.K. Shah et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex Nat Immunol 4 2003 69 77
6. P. Sheppard, W. Kindsvogel, W. Xu, K. Henderson, S. Schlutsmeyer, and T.E. Whitmore et al. IL-28, IL-29 and their class II cytokine receptor IL-28R Nat Immunol 4 2003 63 68
7. M. Li, X. Liu, Y. Zhou, and S.B. Su Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses J Leukoc Biol 86 2009 23 32
8. W.J. Jordan, J. Eskdale, S. Srinivas, V. Pekarek, D. Kelner, and M. Rodia et al. Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response Genes Immun 8 2007 254 261
9. S. Srinivas, J. Dai, J. Eskdale, G.E. Gallagher, N.J. Megjugorac, and G. Gallagher Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro Immunology 125 2008 492 502
10. M. Contoli, S.D. Message, V. Laza-Stanca, M.R. Edwards, P.A. Wark, and N.W. Bartlett et al. Role of deficient type III interferon-lambda production in asthma exacerbations Nat Med 12 2006 1023 1026
11. D.M. Bullens, A. Decraene, E. Dilissen, I. Meyts, K. De Boeck, and L.J. Dupont et al. Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics Clin Exp Allergy 38 2008 1459 1467
12. E.K. Miller, J.Z. Hernandez, V. Wimmenauer, B.E. Shepherd, D. Hijano, and R. Libster et al. A mechanistic role for type III IFN-lambda1 in asthma exacerbations mediated by human rhinoviruses Am J Respir Crit Care Med 185 2012 508 516
13. O. Koltsida, M. Hausding, A. Stavropoulos, S. Koch, G. Tzelepis, and C. Ubel et al. IL-28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease EMBO Mol Med 3 2011 348 361
14. X. Liu, M. Li, Y. Wu, Y. Zhou, L. Zeng, and T. Huang Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma Biochem Biophys Res Commun 386 2009 181 185
15. S.A. Shore, R.D. Terry, L. Flynt, A. Xu, and C. Hug Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice J Allergy Clin Immunol 118 2006 389 395
16. C.C. Wang, C.L. Fu, Y.H. Yang, Y.C. Lo, L.C. Wang, and Y.H. Chuang et al. Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma Gene Ther 13 2006 1414 1421
17. M.C. Li, H.Y. Wang, H.Y. Wang, T. Li, and S.H. He Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cells Acta Pharmacol Sin 27 2006 453 459
18. N.W. Bartlett, K. Buttigieg, S.V. Kotenko, and G.L. Smith Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model J Gen Virol 86 2005 1589 1596
19. K. Izuhara, S. Ohta, H. Shiraishi, S. Suzuki, K. Taniguchi, and S. Toda et al. The mechanism of mucus production in bronchial asthma Curr Med Chem 16 2009 2867 2875
20. F.D. Finkelman, S.P. Hogan, G.K. Hershey, M.E. Rothenberg, and M. Wills-Karp Importance of cytokines in murine allergic airway disease and human asthma J Immunol 184 2010 1663 1674
21. K. Dabbagh, K. Takeyama, H.M. Lee, I.F. Ueki, J.A. Lausier, and J.A. Nadel IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo J Immunol 162 1999 6233 6237
22. W.W. Busse, J. Ring, J. Huss-Marp, and J.E. Kahn A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma J Allergy Clin Immunol 125 2010 803 813
23. T.A. Wynn IL-13 effector functions Annu Rev Immunol 21 2003 425 456
24. C. Ozdemir, M. Akdis, and C.A. Akdis T-cell response to allergens Chem Immunol Allergy 95 2010 22 44
25. J. Hunt, M.G. Bracher, J. Shi, S. Fleury, D. Dombrowicz, and H.J. Gould et al. Attenuation of IgE affinity for FcepsilonRI radically reduces the allergic response in vitro and in vivo J Biol Chem 283 2008 29882 29887
26. M. Akdis, K. Blaser, and C.A. Akdis T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases J Allergy Clin Immunol 116 2005 961 968 [quiz 9]
27. J. Kearley, D.S. Robinson, and C.M. Lloyd CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling J Allergy Clin Immunol 122 2008 617 624 e6
28. F.J. Mennechet, and G. Uze Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells Blood 107 2006 4417 4423